[Nontuberculous mycobacteria in patients with cystic fibrosis]
- PMID: 16266669
- DOI: 10.1016/s1579-2129(06)60283-8
[Nontuberculous mycobacteria in patients with cystic fibrosis]
Abstract
Objective: Patients with cystic fibrosis are at great risk of infection by nontuberculous mycobacteria from the environment because of certain predisposing factors such as bronchiectasis, malnutrition, and diabetes. The aim of this study was to analyze the mycobacterial content of sputum smears and cultures from adult patients with cystic fibrosis attended at a specialized unit for adults from March 1997 through December 2001.
Patients and methods: Sputum samples were collected prospectively according to a protocol applied at each visit, and during most exacerbations staining and culture for mycobacteria were ordered in addition to the usual cultures for bacteria and fungi. A tuberculin test was performed at the end of the study.
Results: Twenty-eight patients (16 men) with cystic fibrosis were enrolled. The mean (SD) age was 25.3 (6.7) years. A total of 251 samples were cultured (range in number of samples per patient, 1-31). The mean period of follow up was 40.3 (22.1) months. The sputum smear was positive in 29 cases (4 patients); the culture was positive in 7 patients. More than 3 samples were positive in only 4 patients. Mycobacterium abscessus was isolated in 3 cases, Mycobacterium avium complex in 2 and Mycobacterium simiae in 1 and other an unidentified rapid growth Mycobacterium species. The Mantoux test was positive in 5 patients. Two of the 4 patients in whose samples mycobacteria were isolated repeatedly required treatment.
Conclusions: The prevalence of nontuberculous mycobacterial infection is high in patients with cystic fibrosis. Staining and culture for mycobacteria should be carried out regularly and whenever exacerbation of pulmonary symptoms cannot be attributed to bacteria usually found in such patients. Patients with recurrent isolations of mycobacteria should be monitored closely.
Similar articles
-
An evaluation of methods for the isolation of nontuberculous mycobacteria from patients with cystic fibrosis, bronchiectasis and patients assessed for lung transplantation.BMC Pulm Med. 2019 Jan 21;19(1):19. doi: 10.1186/s12890-019-0781-2. BMC Pulm Med. 2019. PMID: 30665395 Free PMC article.
-
[Nontuberculous mycobacterial infection in patients with cystic fibrosis: a multicenter prevalence study].Arch Bronconeumol. 2008 Dec;44(12):679-84. Arch Bronconeumol. 2008. PMID: 19091237 Spanish.
-
Prevalence and factors associated with nontuberculous mycobacteria in non-cystic fibrosis bronchiectasis: a multicenter observational study.BMC Infect Dis. 2016 Aug 22;16(1):437. doi: 10.1186/s12879-016-1774-x. BMC Infect Dis. 2016. PMID: 27549788 Free PMC article.
-
Antibiotic treatment for nontuberculous mycobacteria lung infection in people with cystic fibrosis.Cochrane Database Syst Rev. 2012 Dec 12;12:CD010004. doi: 10.1002/14651858.CD010004.pub2. Cochrane Database Syst Rev. 2012. Update in: Cochrane Database Syst Rev. 2014 Dec 03;(12):CD010004. doi: 10.1002/14651858.CD010004.pub3 PMID: 23235684 Updated. Review.
-
Antibiotic treatment for nontuberculous mycobacteria lung infection in people with cystic fibrosis.Cochrane Database Syst Rev. 2014 Dec 3;(12):CD010004. doi: 10.1002/14651858.CD010004.pub3. Cochrane Database Syst Rev. 2014. Update in: Cochrane Database Syst Rev. 2016 Dec 19;12:CD010004. doi: 10.1002/14651858.CD010004.pub4 PMID: 25470304 Updated. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
